CTOs on the Move


 
MSI Methylation Sciences Inc. (“MSI”) is a clinical-stage pharmaceutical company focused on developing new products based on molecules which have clinical proof of concept but which have yet to be exploited in the major pharmaceutical markets. MSI`s focus is in the CNS space where clinical proof of concept is key to reducing the drug development risk. Our lead product candidate, Strada™, is based upon Ademetionine, a naturally occurring molecule produced throughout the body, where it plays a vital role in the one-carbon cycle. Our disease indication is Major Depressive Disorder (MDD).
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

MSI raised $30M on 10/07/2016

Similar Companies

Prime Medica

Prime Medica is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

People

People, Pets and Vets is a doctor-led organization that partners with veterinarians to help them reach their full potential.

Capitol Drugs

Capitol Drugs is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Sherman Oaks, CA. To find more information about Capitol Drugs, please visit www.capitoldrugs.com

getlunacare

Luna physical therapists come to you! We accept all major insurances and Medicare. Serving patients across the United States.

Comprehensive Alcoholism Treatment Program

Comprehensive Alcoholism Treatment Program is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.